文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease.

作者信息

Beyersdorf Friedhelm, Vahanian Alec, Milojevic Milan, Praz Fabien, Baldus Stephan, Bauersachs Johann, Capodanno Davide, Conradi Lenard, De Bonis Michele, De Paulis Ruggero, Delgado Victoria, Freemantle Nick, Gilard Martine, Haugaa Kristina H, Jeppsson Anders, Jüni Peter, Pierard Luc, Prendergast Bernard D, Sádaba J Rafael, Tribouilloy Christophe, Wojakowski Wojtek

出版信息

Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac209.


DOI:10.1093/ejcts/ezac209
PMID:35352803
Abstract
摘要

相似文献

[1]
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease.

Eur J Cardiothorac Surg. 2022-6-15

[2]
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Eur Heart J. 2022-6-1

[3]
Corrigendum to: 2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Eur Heart J. 2018-6-1

[4]
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].

Eur J Cardiothorac Surg. 2017-10-1

[5]
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Eur Heart J. 2021-10-21

[6]
Erratum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease.

Eur J Cardiothorac Surg. 2022-3-24

[7]
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.

Rev Esp Cardiol (Engl Ed). 2018-2

[8]
ESC/EACTS Guidelines on the management of valvular heart disease.

Eur Heart J. 2012-10

[9]
Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease.

Rev Esp Cardiol (Engl Ed). 2022-6

[10]
[ESC/EACTS Guidelines for the management of valvular heart disease: what's new from the cardiac surgeon's perspective].

G Ital Cardiol (Rome). 2022-3

引用本文的文献

[1]
Study protocol for an internahaational prospective non-randomised trial evaluating the long-term outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement for aortic-valve stenosis in patients at risk to severe valve obstruction: the TAVISAR trial.

BMJ Open. 2025-5-24

[2]
Transapical vs. Transaxillary Access in Transcatheter Aortic Valve Implantation: Comparative Mortality and Long-Term Outcomes Using Inverse Probability of Treatment Weighting Analysis.

J Clin Med. 2025-3-25

[3]
AI-Enhanced Prediction of Aortic Stenosis Progression: Insights From the PROGRESSA Study.

JACC Adv. 2024-9-11

[4]
Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks.

J Clin Med. 2023-3-27

[5]
Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation-Rationale and Design.

Biomimetics (Basel). 2022-12-8

[6]
Non-Inferiority of Sutureless Aortic Valve Replacement in the TAVR Era: David versus Goliath.

Life (Basel). 2022-6-29

[7]
Transcatheter Aortic Valve Implantation: A Report on Serbia's First Systematic Program.

Front Cardiovasc Med. 2022-5-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索